MONDAY, April 3, 2023 (HealthDay News) — An experimental targeted drug could provide a fresh chance for people with recurring head and neck cancer that has grown resistant to other treatments, a new clinical trial says. Ficlatuzumab used in combination with the already approved targeted drug cetuximab (Erbitux) significantly improvedContinue Reading

MONDAY, April 3, 2023 (American Heart Association News) — Brain cells have a complex relationship with the blood vessels around them that can greatly affect the vessels’ ability to function, according to a new science report from the American Heart Association. The scientific statement, published Monday in the AHA journalContinue Reading

MONDAY, April 3, 2023 (HealthDay News) – Pope Francis was back delivering Mass on Palm Sunday, just one day after he was released from the hospital following a three-day stay for bronchitis. Francis, 86, celebrated in St. Peter’s Square in Rome as about 60,000 people looked on, carrying palm frondsContinue Reading